Cargando…

Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment

New coronavirus (SARS-CoV-2) treatments and vaccines are under development to combat COVID-19. Several approaches are being used by scientists for investigation, including (1) various small molecule approaches targeting RNA polymerase, 3C-like protease, and RNA endonuclease; and (2) exploration of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koyama, Takahiko, Weeraratne, Dilhan, Snowdon, Jane L., Parida, Laxmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281497/ https://www.ncbi.nlm.nih.gov/pubmed/32357545 http://dx.doi.org/10.3390/pathogens9050324

Ejemplares similares

Analysis on GENIE reveals novel recurrent variants that affect molecular diagnosis of sizable number of cancer patients
por: Koyama, Takahiko, et al.
Publicado: (2019)

Predictive article recommendation using natural language processing and machine learning to support evidence updates in domain-specific knowledge graphs
por: Sharma, Bhuvan, et al.
Publicado: (2020)

Variant analysis of SARS-CoV-2 genomes
por: Koyama, Takahiko, et al.
Publicado: (2020)

Characterizing Pain Points in Clinical Data Management and Assessing the Impact of Mid-Study Updates
por: Harper, Beth, et al.
Publicado: (2021)

Artificial Intelligence and Machine Learning Technologies in Cancer Care: Addressing Disparities, Bias, and Data Diversity
por: Dankwa-Mullan, Irene, et al.
Publicado: (2022)

A Narrative Review of Emerging Therapeutics for COVID-19
por: Willis, Van C., et al.
Publicado: (2020)

Precision Medicine, AI, and the Future of Personalized Health Care
por: Johnson, Kevin B., et al.
Publicado: (2020)

Social distancing plus rapid vaccination prevents emergence of SARS-CoV-2 variants
por: Bordon, Yvonne
Publicado: (2022)

Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant
por: O’Horo, John C., et al.
Publicado: (2022)

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
por: Koyama, Takahiko, et al.
Publicado: (2022)

HIV vaccine development and broadly neutralizing antibodies
por: Greenspan, Neil S., et al.
Publicado: (2015)

Are variant-specific vaccines warranted?
por: Flemming, Alexandra
Publicado: (2022)

Epitope mapping of spike identifies variant-resistant antibodies
por: Flemming, Alexandra
Publicado: (2021)

Clinical insights into hematologic malignancies and comparative analysis of molecular signatures of acute myeloid leukemia in different ethnicities using an artificial intelligence offering
por: Snowdon, Jane L., et al.
Publicado: (2021)

Antibody imaging to speed vaccine work
por: Wong, Carissa
Publicado: (2022)

Characterizing Thrombotic Complication Risk Factors Associated With COVID-19 via Heterogeneous Patient Data: Retrospective Observational Study
por: Rosario, Bedda, et al.
Publicado: (2022)

Medical oncologists’ perspectives of the Veterans Affairs National Precision Oncology Program
por: Vashistha, Vishal, et al.
Publicado: (2020)

Emergency medicine specialty may improve patient satisfaction
por: Abbasi, Saeed, et al.
Publicado: (2014)

Infections and Exposure to Antibiotics May Affect the Development of Late-onset Rather than Early-onset Atopic Dermatitis
por: Choi, Chong Won, et al.
Publicado: (2023)

SARS-CoV-2 variant evades antibodies whilst maintaining fitness
por: Flemming, Alexandra
Publicado: (2021)

Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
por: Edara, Venkata Viswanadh, et al.
Publicado: (2021)

Modeling Infectious Bursal Disease Virus (IBDV) Antigenic Drift In Vitro
por: Asfor, Amin S., et al.
Publicado: (2022)

A Novel Homozygous VPS11 Variant May Cause Generalized Dystonia
por: Monfrini, Edoardo, et al.
Publicado: (2021)

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
por: Andrade, Viviane M., et al.
Publicado: (2021)

Effects of Casirivimab/Imdevimab Monoclonal Antibody Treatment among Vaccinated Patients Infected by SARS-CoV-2 Delta Variant
por: Cicchitto, Gaetano, et al.
Publicado: (2022)

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
por: Koger-Pease, Cal, et al.
Publicado: (2023)

Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains
por: Plant, Ewan P., et al.
Publicado: (2017)

Paramecium BBS genes are key to presence of channels in Cilia
por: Valentine, Megan Smith, et al.
Publicado: (2012)

Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City
por: Cowman, Kelsie, et al.
Publicado: (2021)

Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
por: Ariën, Kevin K., et al.
Publicado: (2022)

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
por: Karaba, Andrew H., et al.
Publicado: (2022)

Epistatic Interactions between CREB and CREM Variants in Affective Disorder
por: Chiesa, Alberto, et al.
Publicado: (2014)

Emergency anaesthetic management of penetrating thoracic trauma: Combining skill with fortuity
por: Gupta, Sumanlata, et al.
Publicado: (2015)

Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies
por: Godi, Anna, et al.
Publicado: (2019)

Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination
por: Funakoshi, Yohei, et al.
Publicado: (2022)

CoronaVac and ChAdOx1 Vaccination and Gamma Infection Elicited Neutralizing Antibodies against the SARS-CoV-2 Delta Variant
por: Fumagalli, Marcilio Jorge, et al.
Publicado: (2022)

Longitudinal Neutralizing and Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants Following Messenger RNA Coronavirus Disease 2019 Vaccination
por: Chen, Xuemin, et al.
Publicado: (2023)

COVID-19 vaccine — can it affect fertility?
por: Schaler, Laurentina, et al.
Publicado: (2021)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

SARS-CoV-2 Omicron BA.2.75 Variant May Be Much More Infective than Preexisting Variants Based on In Silico Model
por: Sugano, Aki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17tk5j0krr33mi0vjq0d17sd08